Fundraising Fox

SpyBiotech

3 known investors

spybiotech.com ↗

SpyBiotech is a clinical-stage biotech company developing vaccines against infectious diseases and cancer using its proprietary SpyTag/SpyCatcher protein "superglue" platform. It applies this technology to create vaccines for viral, bacterial, and parasitic infections as well as therapeutic cancer vaccines.

BiotechDeep TechHealthtech

Investors · 3

Oxford Science EnterprisesOxford · $63.5K – $31.8M
Future FundreportedLondon
GV (Google Ventures)reportedMountain View · $250K – $50M

In the news

SpyBiotech receives more than $4 million to develop vaccine platformlabiotech.eu · Mar 2023News - SpyBiotechspybiotech.com · Nov 2022Our Story - SpyBiotechspybiotech.com · Oct 2022SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support its novel vaccine platform through accelerated clinical developmentfinance.yahoo.com · Feb 2021Oxford startup SpyBiotech raises £4m Seed - UKTNuktech.news · Mar 2017SpyBiotech, which makes a 'superglue' for vaccines, raises £4M from GV and Oxford | TechCrunchtechcrunch.com · Mar 2017

Frequently asked questions

What does SpyBiotech do?
SpyBiotech is a clinical-stage biotech company developing vaccines against infectious diseases and cancer using its proprietary SpyTag/SpyCatcher protein "superglue" platform. It applies this technology to create vaccines for viral, bacterial, and parasitic infections as well as therapeutic cancer vaccines.
Who are SpyBiotech's investors?
SpyBiotech's investors include Oxford Science Enterprises, Future Fund, GV (Google Ventures).